Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre

Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre

Background & objectives: Gemcitabine combined with non-cremophor-based paclitaxel is one of the standards of care in advanced inoperable pancreatic cancer. This study was undertaken to retrospectively evaluate real world non-trial outcomes with this combination. Methods: Patients with histologic...

Full description

Bibliographic Details
Main Authors: Vikas Ostwal, Arvind Sahu, Saurabh Zanwar, Lingaraj Nayak, Shailesh V Shrikhande, Nitin Shetty, Sudeep Gupta, Anant Ramaswamy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Medical Research
Subjects:
Advanced pancreatic cancer - non-cremophor-based paclitaxel-gemcitabine - PDAC - unresectable cancer
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2018;volume=148;issue=3;spage=284;epage=290;aulast=Ostwal

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2018;volume=148;issue=3;spage=284;epage=290;aulast=Ostwal

Similar Items